SCHEMBL1921827

SCHEMBL1921827

Cc1ccc(C)c(Nc2ccccc2Nc2cc(C)ccc2C)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.61
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
GAA P10253 5/20 0.49
HSD17B10 Q99714 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 3/20 0.46
LMNA P02545 2/20 0.46
HCRTR1 O43613 1/20 0.46
TSHR P16473 1/20 0.46
POLB P06746 1/20 0.46
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21241199 0.93 RAPGEF4 (0.59) RAPGEF4MEN1KMT2AGAAHSD17B10
SCHEMBL29196035 0.91 RAPGEF4 (0.71) RAPGEF4MEN1KMT2AGAAHSD17B10
SCHEMBL9629646 0.83 GAA (0.59) RAPGEF4MEN1KMT2AGAARAB9A
SCHEMBL8691617 0.83 RAPGEF4 (0.57) RAPGEF4MEN1KMT2AGAAHSD17B10
SCHEMBL1921160 0.82 RAPGEF4 (0.63) RAPGEF4MEN1KMT2AGAASMN1; SMN2
SCHEMBL17858100 0.82 RAPGEF4 (0.61) RAPGEF4MEN1KMT2AGAAHSD17B10
SCHEMBL28360150 0.82 CYP2C9 (0.49) RAPGEF4MEN1KMT2AGAAHSD17B10
SCHEMBL30575353 0.80 RAPGEF4 (0.61) RAPGEF4MEN1KMT2AGAASMN1; SMN2
SCHEMBL8598906 0.80 RAPGEF4 (0.61) RAPGEF4MEN1KMT2AGAASMN1; SMN2
SCHEMBL1921826 0.79 RAPGEF4 (0.63) RAPGEF4MEN1KMT2AGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139977-B1 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES EXXONMOBIL RES & ENG CO (US) 2012-09-05 EP claimed
US-7759295-B2 Lubricating compositions containing ashless catalytic antioxidant additives EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2010-07-20 US claimed
EP-2139977-A2 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES ExxonMobil Research and Engineering Company (US) 2010-01-06 EP claimed
WO-2008123940-A2 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2008-10-16 WO claimed
US-20080248985-A1 Lubricating compositions containing ashless catalytic antioxidant additives EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2008-10-09 US claimed
EP-1528074-B1 NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF TOSOH CORP (JP) 2014-03-26 EP disclosed
EP-2139977-B1 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES EXXONMOBIL RES & ENG CO (US) 2012-09-05 EP disclosed
EP-2139977-B1 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES EXXONMOBIL RES & ENG CO (US) 2012-09-05 EP disclosed
EP-2327739-A1 Novel triarylamine polymer, process for its production and its use TOSOH CORPORATION (JP) 2011-06-01 EP disclosed
US-20100217043-A1 Lubricating compositions containing ashless catalytic antioxidant additives PATIL ABHIMANYU O 2010-08-26 US disclosed
US-20100217043-A1 Lubricating compositions containing ashless catalytic antioxidant additives PATIL ABHIMANYU O 2010-08-26 US disclosed
US-20100217043-A1 Lubricating compositions containing ashless catalytic antioxidant additives PATIL ABHIMANYU O 2010-08-26 US disclosed
US-20080248985-A1 Lubricating compositions containing ashless catalytic antioxidant additives EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2008-10-09 US disclosed
US-20080248985-A1 Lubricating compositions containing ashless catalytic antioxidant additives EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2008-10-09 US disclosed
US-20080248985-A1 Lubricating compositions containing ashless catalytic antioxidant additives EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2008-10-09 US disclosed
US-20060241278-A1 Novel triarylamine polymer, process for producing the same, and use thereof TOSOH CORPORATION (JP) 2006-10-26 US disclosed
US-20060017040-A9 Novel triarylamine polymer, process for producing the same, and use thereof SUZUKI TAKAO 2006-01-26 US disclosed
EP-1528074-A1 NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Tosoh Corporation (JP) 2005-05-04 EP disclosed
US-20040262574-A1 Novel triarylamine polymer, process for producing the same, and use thereof TOSOH CORPORATION (JP) 2004-12-30 US disclosed
US-6034206-A POLYANILINES; HEAT, CHEMICAL AND SOLVENT RESISTANCE TOSOH CORPORATION (JP) 2000-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100217043-A1 Lubricating compositions containing ashless catalytic antioxidant additives SOD1, GPX4, GPX1 RAPGEF4 4464/4885MEN1 4136/4885KMT2A 2303/4885
US-20080248985-A1 Lubricating compositions containing ashless catalytic antioxidant additives SOD1, GPX4, GPX1 RAPGEF4 4464/4885MEN1 4136/4885KMT2A 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.